New study shows higher efficacy of AstraZeneca in mix-and-match with Medigen

A recent COVID-19 vaccine trial carried out in Taiwan has found that a mix of AstraZenca and the locally developed Medigen is more effective than two doses AstraZeneca, the head of the research team said Saturday.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)